BelHealth Acquires Specialty Pharmacy Targeting Women's Health
August 19, 2015
Marking the second platform investment from its Fund II, BelHealth Investment Partners has announced the acquisition of Apothecary by Design, a specialty pharmacy focused on women's health, hepatitis C and autoimmune disorders. Founded in 2008, the company services fertility patients across the U.S. and other patients throughout the Northeast region. BelHealth Investment Fund II closed on its $350 million hard cap in June; the vehicle's first platform company, Geritrex, was acquired earlier this month.